Illustrative image – not actual.Kabra Drugs has received a letter of intent (LoI) from the Government of Chhattisgarh for the proposed establishment of a pharmaceutical manufacturing facility at Nava Raipur Pharma Park.
The proposed investment represents a key milestone in the company’s long-term growth strategy and is expected to significantly expand its manufacturing capabilities and operational footprint. Located within the strategically developed Nava Raipur Pharma Park, the facility involving an investment of Rs 200 crore is intended to enhance production capacity, improve operational efficiency, and strengthen the company’s position in the rapidly evolving pharmaceutical and healthcare manufacturing sectors. The project is also expected to support regional economic development by generating approximately 250 direct and indirect employment opportunities. Through this expansion, Kabra Drugs aims to capitalise on emerging market opportunities while reinforcing its commitment to innovation and quality manufacturing.
The company anticipates benefiting from applicable state government policies, incentives, approvals, and support mechanisms, subject to statutory compliance and sanction orders. The proposed facility is expected to play a vital role in driving future growth, improving competitiveness, and supporting the company’s long-term vision of becoming a stronger player in India’s pharmaceutical manufacturing landscape.
